The post Vanguard reverses course, opens door to Bitcoin, Ethereum, XRP, and Solana ETFs appeared on BitcoinEthereumNews.com. Vanguard now allows clients to trade Bitcoin, Ethereum, XRP, and Solana ETFs. XRP ETFs have seen $756M inflows in 11 days, with no outflows recorded. Goldman and other firms are boosting crypto exposure alongside Vanguard. In a dramatic shift that signals growing acceptance of digital assets by mainstream finance, Vanguard has opened its brokerage platform to regulated crypto ETFs. Starting this week, US investors can access exchange-traded funds tied to Bitcoin, Ethereum, XRP, and Solana, marking a major reversal from the firm’s long-held resistance to cryptocurrency. 🚨 Just found this on Vanguard’s official website 👀 Multiple XRP ETFs (Franklin, Canary, REX-Osprey, ProShares…) are now showing under « Non-Vanguard Funds » in the Digital Assets category. Looks like access is finally opening up for crypto ETFs pic.twitter.com/Y08IgtAybg — Arthur (@XrpArthur) December 2, 2025 Notably, the move comes amid surging client demand and increasing institutional interest in digital assets, reshaping Vanguard’s traditional investment philosophy. Vanguard finally embraces crypto For years, Vanguard maintained a cautious stance toward cryptocurrencies, with former CEO Tim Buckley publicly dismissing BTC and other digital assets as too speculative and unsuitable for long-term portfolios. The firm consistently refused to offer crypto ETFs, emphasising stability and low-risk investments for retirement-focused clients. However, leadership changes paved the way for a rethink. Salim Ramji, formerly the global head of ETFs at BlackRock, assumed the CEO role and gradually steered Vanguard toward regulated crypto offerings. While the firm still will not create its own crypto ETFs or mutual funds, it now supports third-party products that meet regulatory standards, providing clients with access to digital assets while maintaining compliance. The platform expansion enables more than 50 million US brokerage clients to trade crypto ETFs alongside other non-core assets like gold. This could significantly increase market participation, with some predicting near-term price boosts in Bitcoin (BTC) and… The post Vanguard reverses course, opens door to Bitcoin, Ethereum, XRP, and Solana ETFs appeared on BitcoinEthereumNews.com. Vanguard now allows clients to trade Bitcoin, Ethereum, XRP, and Solana ETFs. XRP ETFs have seen $756M inflows in 11 days, with no outflows recorded. Goldman and other firms are boosting crypto exposure alongside Vanguard. In a dramatic shift that signals growing acceptance of digital assets by mainstream finance, Vanguard has opened its brokerage platform to regulated crypto ETFs. Starting this week, US investors can access exchange-traded funds tied to Bitcoin, Ethereum, XRP, and Solana, marking a major reversal from the firm’s long-held resistance to cryptocurrency. 🚨 Just found this on Vanguard’s official website 👀 Multiple XRP ETFs (Franklin, Canary, REX-Osprey, ProShares…) are now showing under « Non-Vanguard Funds » in the Digital Assets category. Looks like access is finally opening up for crypto ETFs pic.twitter.com/Y08IgtAybg — Arthur (@XrpArthur) December 2, 2025 Notably, the move comes amid surging client demand and increasing institutional interest in digital assets, reshaping Vanguard’s traditional investment philosophy. Vanguard finally embraces crypto For years, Vanguard maintained a cautious stance toward cryptocurrencies, with former CEO Tim Buckley publicly dismissing BTC and other digital assets as too speculative and unsuitable for long-term portfolios. The firm consistently refused to offer crypto ETFs, emphasising stability and low-risk investments for retirement-focused clients. However, leadership changes paved the way for a rethink. Salim Ramji, formerly the global head of ETFs at BlackRock, assumed the CEO role and gradually steered Vanguard toward regulated crypto offerings. While the firm still will not create its own crypto ETFs or mutual funds, it now supports third-party products that meet regulatory standards, providing clients with access to digital assets while maintaining compliance. The platform expansion enables more than 50 million US brokerage clients to trade crypto ETFs alongside other non-core assets like gold. This could significantly increase market participation, with some predicting near-term price boosts in Bitcoin (BTC) and…

Vanguard reverses course, opens door to Bitcoin, Ethereum, XRP, and Solana ETFs

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • Vanguard now allows clients to trade Bitcoin, Ethereum, XRP, and Solana ETFs.
  • XRP ETFs have seen $756M inflows in 11 days, with no outflows recorded.
  • Goldman and other firms are boosting crypto exposure alongside Vanguard.

In a dramatic shift that signals growing acceptance of digital assets by mainstream finance, Vanguard has opened its brokerage platform to regulated crypto ETFs.

Starting this week, US investors can access exchange-traded funds tied to Bitcoin, Ethereum, XRP, and Solana, marking a major reversal from the firm’s long-held resistance to cryptocurrency.

Notably, the move comes amid surging client demand and increasing institutional interest in digital assets, reshaping Vanguard’s traditional investment philosophy.

Vanguard finally embraces crypto

For years, Vanguard maintained a cautious stance toward cryptocurrencies, with former CEO Tim Buckley publicly dismissing BTC and other digital assets as too speculative and unsuitable for long-term portfolios.

The firm consistently refused to offer crypto ETFs, emphasising stability and low-risk investments for retirement-focused clients.

However, leadership changes paved the way for a rethink.

Salim Ramji, formerly the global head of ETFs at BlackRock, assumed the CEO role and gradually steered Vanguard toward regulated crypto offerings.

While the firm still will not create its own crypto ETFs or mutual funds, it now supports third-party products that meet regulatory standards, providing clients with access to digital assets while maintaining compliance.

The platform expansion enables more than 50 million US brokerage clients to trade crypto ETFs alongside other non-core assets like gold.

This could significantly increase market participation, with some predicting near-term price boosts in Bitcoin (BTC) and Ethereum (ETH).

Vanguard’s inclusion of XRP ETFs

Among the new offerings, XRP-based ETFs have generated particular excitement.

In just 11 trading days, spot XRP ETFs have recorded net inflows exceeding $756 million, with total assets under management reaching $723 million.

Remarkably, there have been no outflows, and major inflow events include $243 million during Canary Capital’s launch, $164 million tied to Grayscale and Franklin Templeton ETFs, and $89.65 million in the most recent session.

This rapid accumulation is reducing the liquid XRP supply on exchanges, potentially creating a supply shock that could influence pricing.

Mainstream finance accelerates crypto adoption

Vanguard’s pivot reflects a broader trend among traditional financial institutions embracing crypto.

Goldman Sachs, for example, is deepening its exposure through a $2 billion acquisition of Innovator Capital Management, which issues defined-outcome ETFs, including Bitcoin-linked structured funds.

The bank has rapidly increased its holdings in Bitcoin and Ethereum ETFs, totalling billions in assets, while also developing infrastructure for tokenised financial products.

Industry observers view these moves as part of a gradual yet significant integration of digital assets into mainstream portfolios, indicating that regulated, institutionally backed crypto investment is shifting from a niche to a standard.

The implications of Vanguard’s decision extend beyond immediate market activity.

By allowing access to regulated crypto ETFs, the firm is providing a channel for both retail and institutional investors to participate in digital asset markets within a familiar, compliant framework.

This could draw additional inflows, potentially reshaping liquidity dynamics and market sentiment across Bitcoin, Ethereum, XRP, and Solana.

For Vanguard, the shift represents not only a strategic response to client demand but also an acknowledgement that digital assets have become a permanent fixture in the global financial landscape.

Source: https://coinjournal.net/news/vanguard-reverses-course-opens-door-to-bitcoin-ethereum-xrp-and-solana-etfs/

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.424
$1.424$1.424
+1.62%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
Why YouCam AI API is the Secret Weapon for E-Commerce Startups

Why YouCam AI API is the Secret Weapon for E-Commerce Startups

 The New Standard of Personalized Shopping In an era where digital engagement dictates market share, the transition from “browsing” to “buying” depends on confidence
Share
Techbullion2026/03/25 14:34
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26